1.Role of microenvironment in the pathogenesis of kidney stone
Tianxiang ZHANG ; Xi ZHANG ; Chunjiang HU ; Bo XIAO ; Jianxing LI
Chinese Journal of Urology 2025;46(10):791-795
Kidney stone is a common urological disorder with an increasing annual incidence,posing a heavy social burden. Previous studies have demonstrated that diverse cell death modalities,including ferroptosis and apoptosis,induce renal tubular epithelial cell injury and thereby promote kidney stone formation. Emerging evidence in recent years has further revealed that immune-inflammatory responses driven by interactions among renal microenvironment components also contribute to kidney stone pathogenesis. This review systematically summarizes current research advances on the mechanisms by which inflammatory cellular components(e.g.,macrophages,T cells),inflammatory mediators(e.g.,inflammasomes,cytokines),microbiota,and their synergistic interactions influence kidney stone development within the renal microenvironment.
2.Role of microenvironment in the pathogenesis of kidney stone
Tianxiang ZHANG ; Xi ZHANG ; Chunjiang HU ; Bo XIAO ; Jianxing LI
Chinese Journal of Urology 2025;46(10):791-795
Kidney stone is a common urological disorder with an increasing annual incidence,posing a heavy social burden. Previous studies have demonstrated that diverse cell death modalities,including ferroptosis and apoptosis,induce renal tubular epithelial cell injury and thereby promote kidney stone formation. Emerging evidence in recent years has further revealed that immune-inflammatory responses driven by interactions among renal microenvironment components also contribute to kidney stone pathogenesis. This review systematically summarizes current research advances on the mechanisms by which inflammatory cellular components(e.g.,macrophages,T cells),inflammatory mediators(e.g.,inflammasomes,cytokines),microbiota,and their synergistic interactions influence kidney stone development within the renal microenvironment.
3.Changes and health equity of low vision among children and adolescents in Chongqing during 2018 to 2021
ZHOU Chunjiang, LI Meng, HU Ke, WAN Wenjuan, HUANG Hongyun, LIU Zhiyuan
Chinese Journal of School Health 2022;43(8):1241-1244
Objective:
To understand changes and health equity of low vision in children and adolescents in Chongqing, and to provide reference for student myopia prevention and control.
Methods:
Using longitudinal studies, all school students in grades 1 to grade 12 in Chongqing were examined for visual acuity during 2018 to 2021, and the prevalence as well as changes of low vision were analyzed. In 2021, stratified random sampling was used to evaluate the health equity of uncorrected visual acuity and diopter(spherical equivalent, SE).
Results:
The prevalence of low vision for children and adolescents in Chongqing from 2018 to 2021 was 54.12%, 58.17%, 60.03% and 58.20% respectively. Low vision showed an increasing trend in the first three years and decreased by 1.83% in 2021 as compared with 2020( χ 2 trend =13 870.45, P <0.01). The difference in the detection rate of poor vision among students in different grades was statistically significant( χ 2=17 396.36, 2 093.95, 771.87, P <0.01). From 2018 to 2021, the detection rate of low vision in girls was higher than that of boys( P <0.01). The Gini coefficient was 0.054 57 for uncorrected visual acuity in urban area, higher than in rural areas (0.035 94). Meanwhile, the Gini coefficient of urban and rural SE was 0.065 82, higher than the country (0.049 30). The results showed that myopia in children and adolescents was more uneven in urban areas.
Conclusion
The adjustment of myopia prevention and control strategies in the late stage of the novel coronavirus pneumonia epidemic is related to the reduction of the detection rate of poor vision in children and adolescents in Chongqing. Low vision varied by grade and gender, suggesting tailored myopia prevention and control strategy. The detection rate of poor vision in cities is more uneven than in rural areas, and different myopia prevention and control measures need to be implemented according to regional characteristics.
4. Analysis on clinical characteristics of 316 patients with hydrofluoric acid burns
Pengfei TIAN ; Xin′gang WANG ; Yuanhai ZHANG ; Jianfen ZHANG ; Bin XU ; Zuliang HU ; Chunjiang YE ; Chunmao HAN
Chinese Journal of Burns 2018;34(5):271-276
Objective:
To investigate the clinical characteristics of patients with hydrofluoric acid (HF) burns.
Methods:
Clinical data of 316 patients with HF burns admitted to Zhejiang Quhua Hospital from January 2004 to December 2016 were retrospectively analyzed. Patients were divided into non and mild poisoning group (NMP,
5. Analysis on effects of modified dosage of calcium gluconate on patients with hydrofluoric acid burns not in hands or feet
Yuanhai ZHANG ; Xin′gang WANG ; Pengfei TIAN ; Jianfen ZHANG ; Zuliang HU ; Bin XU ; Chunjiang YE ; Liangfang NI ; Chunmao HAN
Chinese Journal of Burns 2018;34(5):277-282
Objective:
To retrospectively explore the effects of modified dosage of calcium gluconate (CG) on the patients with hydrofluoric acid burns not in hands or feet.
Methods:
One hundred and sixty patients with hydrofluoric acid burns not in hands or feet were hospitalized in our burn ward from January 2004 to December 2017. Based on the dosage of CG at different admission time, 76 patients hospitalized from January 2004 to December 2012 were included in traditional group, and 84 patients hospitalized from January 2013 to December 2017 were included in modified group. For patients in the two groups, subcutaneous injection of CG solution at one time was immediately conducted on admission in topical treatment. In traditional group, the injection was CG solution with mass concentration of 100 g/L. For wounds of superficial partial-thickness and above degree, CG solution was prescribed at the dosage of 50 mg/cm2. Wounds of superficial-thickness or mass fraction of hydrofluoric acid less than 20.0% did not receive injection. In modified group, the mass concentration of CG solution for injection was diluted with normal saline to 25 g/L. For wounds of deep partial-thickness and above degree, CG solution was prescribed at the dosage of (50×mass fraction of hydrofluoric acid) mg/cm2. For wounds of superficial partial-thickness, CG solution was prescribed at the dosage of (25×mass fraction of hydrofluoric acid) mg/cm2. For wounds of superficial-thickness, CG solution was prescribed at the dosage of 2.5 mg/cm2. For systemic treatment, the injection velocity of CG solution via venous access was adjusted according to the level of serum calcium namely total serum calcium of patients in traditional group. In modified group, serum ionized calcium was additionally detected through automatic blood gas analyzer by the bed to regulate the injection velocity of CG via venous access. The incidence rate of hypercalcemia and mortality of patients after treatment in the two groups, and the situation about treatment of survivors in the two groups were analyzed. Data were processed with chi-square test, Fisher′s exact probability test,
6.Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016.
Xiaojuan WANG ; Chunjiang ZHAO ; Henan LI ; Hongbin CHEN ; Longyang JIN ; Zhanwei WANG ; Kang LIAO ; Ji ZENG ; Xiuli XU ; Yan JIN ; Danhong SU ; Wenen LIU ; Zhidong HU ; Bin CAO ; Yunzhuo CHU ; Rong ZHANG ; Yanping LUO ; Bijie HU ; Hui WANG
Chinese Journal of Biotechnology 2018;34(8):1205-1217
To dynamically investigate the distribution and antimicrobial resistance profiles of bacteremia pathogens isolated from different regions in China in 2011, 2013 and 2016. Non-repetitive isolates from nosocomial bloodstream infections were retrospectively collected and detected for antimicrobial susceptibility tests (AST) by agar dilution or microbroth dilution methods. Whonet 5.6 was used to analyze the AST data. Among 2 248 isolates, 1 657 (73.7%) were Gram-negative bacilli and 591 (26.3%) were Gram-positive cocci. The top five bacteremia pathogens were as follows, Escherichia coli (32.6%, 733/2 248), Klebsiella pneumoniae (14.5%, 327/2 248), Staphylococcus aureus (10.0%, 225/2 248), Acinetobacter baumannii (8.7%, 196/2 248) and Pseudomonas aeruginosa (6.2%, 140/2 248). Colistin (96.5%, 1 525/1 581, excluding innate resistant organisms), tigecycline (95.6%, 1 375/1 438, excluding innate resistant organisms), ceftazidine/clavulanate acid (89.2%, 1 112 /1 246), amikacin (86.4%, 1 382/1 599) and meropenem (85.7%, 1 376/1 605) showed relatively high susceptibility against Gram-negative bacilli. While tigecycline, teicoplanin and daptomycin (the susceptibility rates were 100.0%), vancomycin and linezolid (the susceptibility rates were 99.7%) demonstrated high susceptibility against Gram-positive cocci. The prevalence of extended-spectrum β-lactamases (ESBLs)-producing Enterobacteriaceae were 50.6% (206/407), 49.8% (136/273) and 38.9% (167/429) in 2011, 2013 and 2016 respectively; carbapenem-non-susceptible Enterobacteriaceae were 2.2% (9/408), 4.0% (16/402) and 3.9% (17/439) in 2011, 2013 and 2016 respectively; The prevalence of multidrug-resistant A. baumannii (MDRA) was 76.4% (55/72) in 2011, 82.7% (43/52) in 2013 and 87.5% (63/72) in 2016, respectively. The prevalence of multidrug-resistant P. aeruginosa (MDRP) was 9.8% (5/51) in 2011, 20.0% (7/35) in 2013 and 13.0% (7/54) in 2016, respectively. The prevalence of methicillin-resistant S. aureus (MRSA) was 51.9% (41/79) in 2011, 29.7% (19/64) in 2013 and 31.7% (26/82) in 2016, respectively. The prevalence of high level gentamicin resistance (HLGR) of Enterococcus faecium and Enterococcus faecalis were 43.2% (48/111) and 40.9% (27/66), respectively. The predominant organism of carbapenem-non-susceptible Enterobacteriaceae was K. pneumoniae with its proportion of 57.1% (24/42). Among 30 tigecycline-non-susceptible Enterobacteriaceae, K. pneumoniae was the most popular organism with 76.7% (23/30). Among 39 colistin-resistant Enterobacteriaceae, E. coli, Enterobacter cloacae and K. pneumoniae were constituted with the percent of 43.6 (17/39), 35.9 (14/39) and 15.4 (6/39), respectively. The Gram-negative bacilli (E. coli and K. pneumoniae were the major organisms) were the major pathogens of nosocomial bacteremia, to which tigecycline, colistin and carbapenems kept with highly in vitro susceptibility. Whereas, among the Gram-positive cocci, S. aureus was the top 1 isolated organism, followed by E. faecium, to which tigecycline, daptomycin, linezolid, vancomycin and teicoplanin kept with highly in vitro susceptibility. Isolation of colistin-resistant Enterobacteriaceae, tigecycline-non-susceptible Enterobacteriaceae, linezolid- or vancomycin-non-susceptible Gram-positive cocci suggests more attention should be paid to these resistant organisms and dynamic surveillance was essential.
7.Clinical Observation of Sofren Injection Combined with Vinpocetine Injection in the Treatment of Acute Massive Cerebral Infarction
Bing CAO ; Qi DING ; Xipeng LIU ; Chunjiang LIU ; Songhua HU
China Pharmacy 2017;28(32):4527-4529
OBJECTIVE:To investigate clinical efficacy of Sofren injection combined with Vinpocetine injection in the treatment of acute massive cerebral infarction,and its effects on hemorheological indexes and serum NOS.METHODS:A total of 60 patients with acute massive cerebral infarction in our hospital during Jan.2014-Jun.2016 were selected as research objects and divided into trial group and control group according to random number table,with 30 cases in each group.Control group was given Citicoline injection 0.5 g,ivgtt,qd.Trial group was additionally given Vinpocetine injection 20 mg added into 0.9% Sodium chloride injection 250 mL,ivgtt,qd;1 h later washing tube,they were given Sofren injection 10 mL added into 0.9% Sodium chloride injection 250 mL,ivgtt,for consecutive 14 d.Clinical efficacies and safety of 2 groups were observed,and hemorheological indexes and NOS levels were observed before and after treatment.RESULTS:The total response rate (83.33%)of trial group was significantly higher than that (50.00%) of control group,with statistical significance (P<0.05).Before treatment,there was no statistical significance in hemorheological indexes or serum NOS levels between 2 groups (P>0.05).After treatment,hemorheological indexes of 2 groups were decreased significantly,and the trial group was significantly lower than the control group.The level of serum NOS in 2 groups were increased significantly,and the trial group was significantly higher than the control group,with statistical significance (P<0.05).No obvious ADR was found in 2 groups.CONCLUSIONS:Sofren injection combined with Vinpocetine injection show significant therapeutic efficacy for acute massive cerebral infarction,can reduce blood viscosity and increase blood perfusion with good safety.
8.Antimicrobial resistance surveillance of gram-positive cocci isolated from 15 teaching hospitals in China in 2013
Yu GUO ; Hui WANG ; Chunjiang ZHAO ; Feifei ZHANG ; Zhanwei WANG ; Bin CAO ; Yingchun XU ; Minjun CHEN ; Bijie HU ; Yuxing NI ; Liyan ZHANG ; Kang LIAO ; Qing YANG ; Yunsong YU ; Xiuli XU ; Yunzhuo CHU ; Zhidong HU ; Ziyong SUN ; Yaning MEI ; Zhiyong LIU
Chinese Journal of Laboratory Medicine 2015;(6):373-381
Objective Toinvestigateantimicrobialresistanceamonggram-positivecocciinChinain 2013.Methods Retrospectivestudy.FromJune2013toDecember2013,1663consecutiveandnon-repetitive gram-positive cocci were collected from 15 teaching hospitals. The minimal inhibitory concentration ( MIC) of antibacterial agents was determined by agar dilution method. A retrospective study was conducted on rates of resistance to antimicrobial agents. The prevalence of penicillin-resistant Streptococcus pneumoniae ( PRSP) between children and adult patients and the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) between elder group and younger adult patients were compared using chi-square test. Results The prevalence of PRSP in children below 3 years old ( 72. 9%, 51/70 ) was higher than adult patients (55. 2%, 106/192) (χ2 =6. 653,P<0. 05). About 94. 9%(261/275) and (92. 7%,255/275) of S. pneumonia were resistant to erythromycin and clindamycin. All S. pneumoniae strains were susceptible to teicoplanin, vancomycin, linezolid, tigecycline and daptomycin. Penicillin still showed very high activity against Streptococcus spp. β-Hemolytic group. More than 60% of Streptococcus spp.β-Hemolytic group were resistant to erythromycin, clindamycin and tetracyclines. The prevalence of MRSA and methicillin-resistant coagulase-negative Staphylococci(MRCoNS) was 39. 7%(229/576) and 80. 6%(224/278), respectively. The MRSA prevalence ranged from 24. 2% to 70. 0% in different regions. About 52. 6%( 100/190 ) of Staphylococcus aureus from respiratory tract specimens, 38. 5%(40/104)of Staphylococcus aureus from blood samples, and 29. 7%(58/195) of Staphylococcus aureus from wound and pus were resistant to methicillin. The prevalence of MRSA in elder group ( 48. 6%, 84/173 ) was higher than that in younger adult patients (35. 7%, 144/403)(χ2 =8. 322,P <0. 05). The susceptibility rates of MRSA to chloramphenicol and trimethoprim/sulfamethoxazole were 86. 4% ( 244/228 ) and 94. 7% ( 237/228 ) , respectively. Susceptibility rates to gentamycin, erythromycin, clindamycin, tetracyclines, rifampicin and quinolones were ranged from 15. 8% to 59. 6%. All Staphylococci isolates were susceptible to teicoplanin, vancomycin, linezolid, daptomycin and tigecycline. All Enterococcus isolates were susceptible to daptomycin and tigecycline. All E. faecalis ( 158/158 ) and 96. 4% ( 133/138 ) of E. faecium were susceptible to teicoplanin. About 98. 0% ( 150/153 ) of E. faecalis and 97. 1% ( 145/138 ) of E. faecium were susceptible to linezoild. About 45. 8% (70/153) of E. faecalis and 60. 9% (84/138) of E. faecium were resistant to gentamycin with a high concentration. The susceptibility of E. faecalis to all the antibiotics tested exceptchloramphenicolandtetracyclinewashigherthanthatofE.faecium.Conclusions Basedon different age groups and regions, the resistance rates of Gram-positive cocci are different. Teicoplanin, vancomycin, tigecycline, daptomycin, linezolid and tedizolid showed very high activity against Gram-positive cocci. (Chin J Lab Med,2015,38:373-381)
9.Antimicrobial resistance surveillance of gram-positive cocci isolated from 14 hospitals in China in 2011
Yu GUO ; Hui WANG ; Chunjiang ZHAO ; Zhanwei WANG ; Feifei ZHANG ; Bin CAO ; Bijie HU ; Kang LIAO ; Yaning MEI ; Qing YANG ; Yingchun XU ; Minjun CHEN ; Zhidong HU ; Ziyong SUN ; Liyan ZHANG ; Yunsong YU ; Yunzhuo CHU ; Xiuli XU ; Yuxing NI
Chinese Journal of Laboratory Medicine 2012;(11):1021-1028
Objective To investigate antimicrobial resistance among gram-positive cocci in 14 teaching hospitals in China in 2011.Methods From June 2011 to December 2011,1498 consecutive and non-repetitive gram-positive cocci were collected from 14 teaching hospitals.The minimal inhibitory concentration (MIC) of antibacterial agents was determined by agar dilution method.A retrospective study was conducted on rates of resistance to antimicrobial agents.Data was compared using chi-square test.Results The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and methicillinresistant coagulase-negative Staphylococci (MRCoNS) was 43.7% (222/508),and 85.6% (214/250),respectively.The MRSA prevalence ranged from 20.0% to 63.5% in different regions.About 58.2% (82/141) of Staphylococcus aureus from respiratory tract specimens,44.8% (48/107) of Staphylococcus aureus from blood samples,and 23.8% (31/130) of Staphylococcus aureus from pus and wound were resistant to methicillin.The susceptible rates of MRSA to chloramphenicol and sulfamethoxazole-trimethoprim SXT were 94.1% (209/222) and 83.3% (185/222),respectively.Susceptibility to gentamycin,erythromycin,clindamycin,tetracyclines,rifampicin and quinolones were from 11.3% to 52.3%.All Staphylococci isolates were susceptible to vancomycin,teicoplanin,linezolid and daptomycin.Five vancomycin-resistant enterococcus (VRE) strains were found in this study.All enterococcus isolates were susceptible to daptomycin(268/268),and 98.3% (118/120) of E.faecalis and 99.3% (147/148) of E.faecium were susceptible to linezoild.About 45.9% (68/148) of E.faecalis and 67.5% (81/120) of E.faecium were resistant to high concentration gentamycin.The susceptibility of E.faecalis to all the antibiotics except for chloramphenicol and tetracycline was higher than that of E.faecium.The prevalence of penicillinnonsusceptible Streptococcus pneumoniae (PNSSP) was 15.5% (37/239).The prevalence of PNSSP in children below 3 years-old was 25% (13/52),and the prevalence of PNSSP from other patients was 13%(24/187).About 91.6% (219/239),88.7% (212/239) and 88.3% (211/239) of S.pneumonia was resistant to erythromycin,clindamycin and tetracyclines.All S.pneumoniae strains were susceptible to teicoplanin,vancomycin,linezolid,tigecycline and daptomycin.Penicillin still showed high activity against Streptococcus spp.β-hemolytic group.More than 60% of Streptococcus.spp.β-hemolytic group are resistant to erythromycin,clindamycin and tetracyclines.Conclusions Based on regions,the resistance rates of Gram-positive cocci are different,of which,the increasing tendency should be taken seriously.Teicoplanin,vancomycin,linezolid,tigecycline and daptomycin show very high activity against Gram-positive cocci.
10.Report from Chinese Meropenem Susceptibility Surveillance in 2010 : antimicrobial resistance among nosocomial gram-negative bacilli
Hui WANG ; Chunjiang ZHAO ; Zhanwei WANG ; Yuxing NI ; Minjun CHEN ; Yingchun XU ; Yunsong YU ; Liyan ZHANG ; Yaning MEI ; Yunzhuo CHU ; Zhidong HU ; Kang LIAO ; Xiaobing ZHANG ; Ziyong SUN ; Xiuli XU ; Xinhong HUANG ; Feifei ZHANG ; Jixia ZHANG ; Qi WANG
Chinese Journal of Laboratory Medicine 2011;34(10):897-904
Objective To investigate antimicrobial resistance among gram-negative bacilli in China in 2010.Methods A total of 1 259 consecutive and non-repetitive gram-negative bacilli were isolated from 13 teaching hospitals from September to December in 2010 in China.All of these isolates were sent to the central laboratory for re-identification and susceptibility testing.The MIC of meropenem and other antibacterial agents were determined by agar dilution method.Interpretive results was determined by CLSI M100-S21.Results The activity of 14 antibacterial agents against 845 Enterobacteriaceae isolates was as follows in order:meropenem ( 98.1%,829 ),amikacin ( 94.0%,794 ),imipeuem ( 90.0%,761 ),piperacillin/tazobactam ( 87.5%,739 ),cefepime ( 83.0%,701 ),ertapenem ( 82.4%,696 ),cefoperazone/sulbactam ( 80.3%,678 ),colistin (75.4%,637),ceftazidime (70.0%,591 ),ciprofloxacin (59.1%,499 ),cefoxitin ( 54.8%,463 ),ceftriaxone ( 53.5%,452 ),cefotaxime ( 52.3%,442 ) and minocycline(51.5%,435).The prevalence of ESBL was 61.3% (106/173) in Escherichia coli,which was much higher than 41.2% (70/170) in Klebsiella pneumoniae.The susceptibility rate of Klebsiella pneumoniae against meropenem,imipenem,amikacin and colistin were more than 90%,but were highly resistant to ceftriaxone and cefotaxime.Over 80% of Enterobacter cloacae,Enterobacter aerogenes,Citrobacter freundii,were susceptible to meropenem,amikacin,cefepine,cefoperazone/sulbactam,imipenem,piperacillin/ tazobactam,and ertapenem.The most active antibiotics against Pseudomonas aeruginosa were Colistin (98.4%,182),Amikacin ( 85.9%,159 ),Piperacillin/Tazobactam ( 80%,148 ),Ceftazidime ( 79.5%,147),Meropenem (74.1%,137),Ciprofloxacin (74.1%,137),Cefepime (73.5%,136),Imipenem (71.9%,132) and Cefoperazone/Sulbactam (70.8%,131 ).Less than 37% of Acinetobacter baumannii isolates were resistant to carbapenems.The susceptible rate to Minocycline was 47.8%.Colistin kept good activity against Acinetobacter baumannii (susceptible rate,97.8%,n =176),The prevalence of Pan-drug resistant P.aeruginosa and A.baumannii was 18.9% (n =35),and 61.8% (n =108),respectively.Conclusions Carbapenems remained very high activity against Enterobacteriaceae.Increasing resistance to the antimicrobials agents test among A.baumanni and P.aeruginosa,especially carbapenems among A.baumanni brought great concern.


Result Analysis
Print
Save
E-mail